Cenestin: profile and news

FDA Sends Duramed Warning Letter Over Cenestin Ad  Jan 18, 2006
2006 - The Food and Drug Administration today posted on its website a warning letter sent to Duramed Pharmaceuticals over an advertisement for Cenestin tablets ... - PharmaLive.com (press release),

NJ drugmaker hits roadblock on contraceptive  Jan 30, 2006
Nearly half of Barr's revenue comes from women's health products, including Cenestin, a synthetic estrogen pill for hot flashes and other menopause symptoms ... - Philadelphia Inquirer,

UPDATE 1-Barr hormone ad was misleading, US FDA says  Jan 18, 2006
WASHINGTON, Jan 18 (Reuters) - A Barr Pharmaceuticals Inc. (BRL.N: Quote, Profile, Research) advertisement for its hormone treatment Cenestin made misleading ... - Reuters

A look at the business of Barr Pharmaceuticals  Jan 22, 2006
...through June 2005). TOP BRAND-NAME DRUGS: Contraceptives Plan B, Seasonale and ParaGard; menopause treatment Cenestin. STATES WHERE ... - Newsday,

Barr Names G. Frederick Wilkinson President and COO of Duramed ...  Jan 10, 2006
These products include the Company's SEASONALE(R) extended-cycle oral contraceptive, Cenestin(R) hormonal agent, Plan B(R) emergency contraceptive and ParaGard ... - PR Newswire (press release),

Barr Names G. Frederick Wilkinson President and COO of Duramed ...  Jan 10, 2006
These products include the Company's SEASONALE® extended-cycle oral contraceptive, Cenestin® hormonal agent, Plan B® emergency contraceptive and ParaGard ... - Yahoo! News (press release)

Menopause years especially tough for female executives  Oct 10, 2005
Simon said he was not compensated for the survey by Barr Laboratories of Woodcliff Lake, NJ The company makes Cenestin, a synthetic, plant-derived prescription ... - Foster's Daily Democrat,

Menopausal Symptoms Challenge Female Baby Boomers in The Workplace  Sep 28, 2005
..."Low-dose plant-derived estrogen therapy products such as Cenestin(R) are available that are proven to consistently relieve the symptoms associated with ... - PR Newswire (press release),

Menopause takes toll on job performance, execs say  Sep 25, 2005
...of the National Association of Female Executives sponsored by Barr Laboratories of Woodcliff Lake, NJ, maker of the menopause drug Cenestin, indicated 95 ... - Chicago Sun-Times,

Barr Reports GAAP Earnings of $2.03 Per Share for Fiscal 2005 and ...  08 Sep 2005
...subsidiary, Duramed Pharmaceuticals, Inc., did not properly terminate its contract with Solvay regarding the joint promotion of Duramed's Cenestin(R) Tablets ... - PR Newswire (press release),

Plan B turns into a quiet success  Aug 3, 2005
...through its 226 sales representatives, who primarily focus on two larger-selling products: its Seasonale birth-control pill and Cenestin hormone-replacement ... - NorthJersey.com

Latest Stock Information  Jul 18, 2005
California's antitrust and unfair competition laws by engaging in anti-competitive and exclusionary conduct that blocked consumer access to Cenestin(R), which ... - TMCnet (press release) <**results**>

Duramed Pharmaceuticals Selects StayinFront for Integrated CRM ...  Jul 1, 2005
Inc., a subsidiary of Barr Pharmaceuticals, Inc., currently markets SEASONALE® extended-cycle oral contraceptive, Cenestin® (Synthetic Conjugated Estrogens, A ... - Yahoo News (press release)

Duramed Pharmaceuticals Selects StayinFront for Integrated CRM ...  Jul 1, 2005
Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc., currently markets SEASONALE(R) extended-cycle oral contraceptive, Cenestin(R) (Synthetic ... - PharmaLive.com (press release),

Consumer News  Apr 26, 2005
Barr Pharmaceuticals Inc., the maker of the Cenestin plant-derived hormone therapy, said US regulators rejected its application to sell the Bijuva estrogen ... - Salt Lake Tribune,